23 / 26
Page 60
conferenceseries
.com
Volume 05
Neonatal and Pediatric Medicine
ISSN: 2572-4983
World Pediatrics 2019
December 04-05, 2019
December 04-05, 2019 | Barcelona, Spain
32
nd
World Pediatrics Conference
Factors influencing intention to obtain the HPV vaccine among a population of university women in
Morocco
Aicha Yacouti
Morocco
C
ervical cancer is a public health problem in the world with approximately 527 624 new cases and 265 672 deaths
annually of which more than 86% occur within developing countries. In Morocco, cervical cancer is the second
women’s cancer after the breast cancer, with an estimated of 2258 new cases and 1076 deaths annually. The last decade
has been marked by the introduction of a vaccine against this cancer. It is clear that the possibility of preventing cervical
cancer through vaccination is an invaluable opportunity but also it is a difficult challenge. Young girls between the ages
of 9 and 26 represent the target population for the HPV vaccine. As a result, the decision to vaccinate depends largely on
two populations; young girls and their parents. The adoption of this vaccination by the population is dependent on several
factors, in particular socio-economic. Thus, in this work we are interested in evaluating the knowledge and attitudes of
university girls towards this vaccine. To this end, we conducted a multicenter survey with 1087 young woman in different
regions of Morocco. The results show that 70.4% of participants are sensitized towards cervical cancer, 85% of whom said
they have never heard of HPV. The rate of sensitization to HPV vaccination is about 7.8%. The rate of HPV vaccination
coverage in our study population does not exceed 0.09%. Only one participant reported being vaccinated. The Analysis
of the results showed, that the main barriers to the practice of this vaccine among participants sensitized towards HPV
vaccine are as follows; the need for more information about the vaccine (40.5%), the fear of side effects (19%) and the need
for a medical prescription (10.7%).
After sensitizing all participants towards HPV and its means of preventing, we recorded an acceptability rate of anti-
HPV vaccination of about 68%. The main barriers reported by participants who expressed their refusal to practice HPV
vaccination are: price (48.1%), fear of side effects (14.8%). In addition, age, family income, branch of study, educational level
of parents and awareness of HPV vaccine and cervical cancer were found as a factors influencing the acceptability of this
vaccine. Our study revealed a low level of awareness and knowledge about HPV and HPV vaccination. Similarly, we have
focused on reticence to this vaccine in our study population. This situation will not help to improve the prevention of this
cancer in our country, which requires the establishment of awareness actions towards the disease and its means of primary
and secondary prevention. The cost of this vaccine is a universal barrier. As a result, the introduction of HPV vaccination
into the national immunization program, or its reimbursement by social security, will encourage a large population to be
vaccinated. In addition, efforts must bemade to sensitize physicians on their axial role in raising awareness and prescribing
this vaccine.
Neonat Pediatr Med 2019, Volume: 05